Clinical Trials
2 trialsNCT01760226 2025-10-14
DA-EPOCH-R
Baylor College of Medicine
Phase EARLY_PHASE1 Completed
NCT01888952 2017-02-27
Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed